Cardinal Health vs Johnson & Johnson: Founders, CEOs and History
Cardinal Health was founded in 1971 by Robert D. Walter and is led by Jason M. Hollar. Johnson & Johnson was founded in 1886 by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson and is led by Joaquin Duato.
Company facts
Cardinal Health
- Founded
- 1971
- Headquarters
- Dublin, Ohio, United States
- Current CEO
- Jason M. Hollar
- Employees
- 63,900
Johnson & Johnson
- Founded
- 1886
- Headquarters
- New Brunswick, New Jersey
- Current CEO
- Joaquin Duato
- Employees
- 140,800
Founders
Cardinal Health
Robert D. Walter
Cardinal Health possesses a unique and unexpected founding history: the pharmaceutical distributor was not founded by a doctor or a pharmacist, but rather by an ambitious entrepreneur attempting to consolidate the wholesale food industry.
Johnson & Johnson
Robert Wood Johnson
Robert Wood Johnson (1845-1910) co-founded Johnson & Johnson in 1886 and served as its first president.
James Wood Johnson
James Wood Johnson (1856-1932) co-founded J&J with his brothers in 1886. An engineer by trade, he designed the early manufacturing machinery that allowed the company to mass-produce sterile surgical dressings.
Edward Mead Johnson
Edward Mead Johnson (1852-1934) co-founded J&J in 1886, bringing crucial sales and marketing expertise to the early business.
CEOs and their tenures
Cardinal Health
- Robert D. Walter1971–2006
Founder, Chairman, and CEO
Walter founded Cardinal Health in 1971 as a food wholesaler and pivoted to pharmaceutical distribution in 1979. He executed dozens of acquisitions that transformed the company from a small regional distributor into a $50+ billion healthcare conglomerate.
Source - Kerry Clark2006–2009
Chairman and CEO
Clark led Cardinal Health through a period of strategic repositioning, including the spin-off of the CareFusion medical technology business. He focused on improving operational efficiency and addressing the challenges of the post-Walter era.
Source - George Barrett2009–2017
Chairman and CEO
Barrett led Cardinal Health through significant strategic initiatives including the acquisition of the Patient Recovery business from Medtronic ($6.1 billion) and the establishment of the Red Oak Sourcing joint venture with CVS Health.
Source - Mike Kaufmann2018–2022
CEO
Kaufmann led Cardinal Health through the opioid litigation settlement and the COVID-19 pandemic, which created demand for medical supplies and pharmaceuticals. He focused on operational execution and maintaining supply chain continuity during the crisis.
Source - Jason M. Hollar2022–present
CEO
Hollar joined Cardinal Health as CFO in 2020 and became CEO in September 2022. He has led the company through the OptumRx contract exit, the GMPD improvement plan, and acquisitions including GI Alliance, ADSG, and Solaris Health.
Source
Johnson & Johnson
- Ralph Larsen1989–2002
Former Chairman and Chief Executive Officer
Larsen's acquisitions, including Neutrogena, Cordis, DePuy, and Centocor, broadened J&J into medical devices and biologics, laying groundwork for today's MedTech segment and immunology franchise.
Source - William Weldon2002–2012
Former Chairman and Chief Executive Officer
Weldon's later years were overshadowed by a wave of consumer product recalls, including Tylenol and Motrin, tied to manufacturing-quality problems.
Source - Alex Gorsky2012–2022
Former Chairman and Chief Executive Officer
Gorsky's tenure set up the 2023 Kenvue separation completed under his successor and saw J&J's single-dose COVID-19 vaccine authorized in 2021. He also oversaw the $30 billion Actelion acquisition in 2017 and the early years of talc litigation.
Source - Joaquin Duato2022–present
Chairman and Chief Executive Officer
Under Duato, J&J's sales reached $94.193 billion in FY2025 with $26.804 billion in net earnings, and the company guides to its first $100 billion year in 2026. He also launched the DePuy Synthes separation and the 2026 talc settlement proposal.
Source
Timeline: Cardinal Health and Johnson & Johnson side by side
1886Johnson & Johnson
Johnson & Johnson Founded
Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson found the company in New Brunswick, New Jersey, with 14 employees, to mass-produce sterile surgical dressings after Robert was inspired by antiseptic pioneer Joseph Lister's 1885 warnings about i…
1920Johnson & Johnson
Band-Aid Brand Adhesive Bandages Introduced
J&J introduces the first mass-produced adhesive bandage, sold under the Band-Aid brand starting in 1921; it becomes one of the most recognized consumer-health brands in the world before J&J later spins its consumer division out as Kenvue in 2023.
1943Johnson & Johnson
Robert Wood Johnson II Writes 'Our Credo'
Chairman Robert Wood Johnson II authors 'Our Credo,' a one-page statement ranking the company's responsibilities to customers, employees, communities, and shareholders in that order; it remains J&J's official governing philosophy and was later cited as the bas…
1944Johnson & Johnson
J&J Goes Public
Johnson & Johnson lists publicly, becoming an independent, market-traded company as it expands into a diversified healthcare business under Chairman Robert Wood Johnson II.
1971Cardinal Health
Cardinal Foods Founded by Robert D. Walter
Robert D. Walter, a 26-year-old Harvard MBA graduate, borrowed $1.3 million to acquire the food-distribution division of Consolidated Foods in a leveraged buyout, establishing Cardinal Foods in Columbus, Ohio.
1979Cardinal Health
Pivot to Pharmaceutical Distribution
Walter acquired Bailey Drug Co., a pharmaceutical distributor in Zanesville, Ohio, marking Cardinal's entry into pharmaceutical distribution.
1982Johnson & Johnson
Tylenol Cyanide Poisonings and Nationwide Recall
After seven people in the Chicago area die from cyanide-laced Extra-Strength Tylenol capsules, J&J issues a nationwide recall of 31 million bottles within a week -- far beyond what investigators said was necessary -- citing Our Credo's customer-safety priority…
1983Cardinal Health
Cardinal Distribution Goes Public
Cardinal Distribution Inc. completed its initial public offering on the NASDAQ at $1.03 per share, providing capital for continued expansion through acquisitions.
1984Cardinal Health
Acquisition of Ellicott Drug
Cardinal acquired Ellicott Drug, a pharmaceutical distributor in Buffalo, New York, continuing the acquisition-driven expansion strategy that would define the company's growth for decades.
1988Cardinal Health
Sale of Food Operations to Roundy's Inc.
Cardinal sold its remaining food operations to Roundy's Inc., completing the company's transition from a diversified food and drug distributor to a pure-play pharmaceutical distribution company.
1994Cardinal Health
Name Change to Cardinal Health
The company changed its name from Cardinal Distribution to Cardinal Health, reflecting its expanding mission beyond pure distribution into healthcare services, manufacturing, and technology. Revenues exceeded $1 billion by 1991.
1995Cardinal Health
Acquisition of Medicine Shoppe International
Cardinal acquired Medicine Shoppe International, the country's largest franchise of retail pharmacies, marking the company's first significant non-distribution acquisition and entry into retail pharmacy.
1996Cardinal Health
Acquisition of Pyxis Corp.
Cardinal acquired Pyxis Corp., a manufacturer of automated supply and pharmaceutical dispensing systems for hospitals, adding medical technology capabilities to the company's portfolio.
1999Cardinal Health
Acquisition of Allegiance Healthcare Corp.
Cardinal acquired Allegiance Healthcare Corp. for approximately $4.4 billion, becoming a major player in the medical-surgical products market and establishing the foundation for what would become the Global Medical Products and Distribution segment.
2012Johnson & Johnson
Alex Gorsky Becomes CEO
Gorsky succeeds William Weldon as CEO amid a period of manufacturing-quality recalls, and spends the next decade restoring J&J's operational reputation while expanding the pharmaceutical and MedTech businesses and developing a single-dose COVID-19 vaccine duri…
2013Cardinal Health
Red Oak Sourcing Joint Venture with CVS
Cardinal Health and CVS Caremark announced the creation of Red Oak Sourcing, a 50/50 joint venture to form the largest generic pharmaceutical sourcing entity in the United States. The venture began operations in July 2014 with an initial 10-year term.
2014Cardinal Health
Loss of Walgreens Contract
Cardinal Health lost a major pharmaceutical distribution contract with Walgreens, which shifted its distribution to AmerisourceBergen. The contract had generated $3.3 billion in quarterly revenue.
2017Cardinal Health
Acquisition of Patient Recovery Business from Medtronic
Cardinal Health acquired the Patient Recovery business from Medtronic for $6.1 billion, expanding its medical products portfolio and adding significant scale to the Global Medical Products and Distribution segment.
2022Johnson & Johnson
Joaquin Duato Becomes CEO
Duato becomes CEO in January 2022, later adding the chairman title, and begins preparing the separation of J&J's consumer-health business from its medicine and device operations.
2023Johnson & Johnson
Kenvue Separation
J&J completes the spinoff of its consumer-health business (Band-Aid, Tylenol, Listerine, Neutrogena) as the standalone public company Kenvue, narrowing J&J around its higher-margin Innovative Medicine and MedTech segments.
2024Cardinal Health
OptumRx Contract Non-Renewal Announced
Cardinal Health's pharmaceutical distribution contracts with OptumRx (part of UnitedHealth Group) expired at the end of June 2024 and were not renewed. They represented about $38.1 billion of fiscal 2024 revenue.
2025Cardinal Health
Fiscal 2025 Results and Raised FY2026 Guidance
Cardinal Health reported fiscal 2025 revenue of $222.6 billion, down about 2% after the OptumRx contract expiration, while net earnings rose to about $1.6 billion.
2025Johnson & Johnson
FY2025 Sales of $94.193B
Johnson & Johnson reports $94.193 billion in sales and $26.804 billion in net earnings, split roughly 64% Innovative Medicine and 36% MedTech, both segments growing about 6% year over year.
2025Johnson & Johnson
Orthopaedics Separation Announced
In October 2025 J&J announced plans to separate its orthopaedics business as a standalone company operating as DePuy Synthes, targeting completion in 2027.
2026Cardinal Health
Fiscal 2026 Revenue Reaches $254.2 Billion
Fiscal 2026 revenue rose 14% to $254.2 billion and non-GAAP EPS rose 37% to $11.26, with profit growth in all five operating segments.
2026Johnson & Johnson
Proposed Talc Resolution and Raised Guidance
J&J raised 2026 sales guidance to about $101.1 billion after Q2 sales of $25.31 billion, and on July 27, 2026 proposed an estimated $5.5 billion resolution of remaining ovarian talc claims.
Acquisitions
Cardinal Health
- Advanced Diabetes Supply Group (ADSG)2025$1.1B
- Solaris Health (via The Specialty Alliance)2025$1.9B
- Integrated Oncology Network (ION)2024Undisclosed
- GI Alliance (71% stake)2024$2.8B
- Patient Recovery Business from Medtronic2017$6.1B
- Allegiance Healthcare Corp.1999Undisclosed
Johnson & Johnson
- Intra-Cellular Therapies2025$14.6B
- Shockwave Medical2024$13.1B
- Kenvue separation2023Undisclosed
- Abiomed2022$16.6B
- Actelion2017$30B
Questions about Cardinal Health vs Johnson & Johnson
Who is the CEO of Cardinal Health, Inc. and Johnson & Johnson?
Cardinal Health, Inc. is led by Jason M. Hollar and Johnson & Johnson is led by Joaquin Duato. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Cardinal Health, Inc. founded vs Johnson & Johnson?
Johnson & Johnson was founded in 1886 — 85 years before Cardinal Health, Inc., which was founded in 1971. Johnson & Johnson's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Cardinal Health, Inc..
How many employees does Cardinal Health, Inc. have compared to Johnson & Johnson?
Cardinal Health, Inc. employs approximately 63,900 people, while Johnson & Johnson employs approximately 140,800. Johnson & Johnson has the larger workforce at 140,800 employees, compared to Cardinal Health, Inc.'s 63,900. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Cardinal Health, Inc. and Johnson & Johnson headquartered?
Both Cardinal Health, Inc. and Johnson & Johnson are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Cardinal Health, Inc. and Johnson & Johnson?
Cardinal Health, Inc. was founded by Robert D. Walter. Johnson & Johnson was founded by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson.
Which company has a longer operating history — Cardinal Health, Inc. or Johnson & Johnson?
Johnson & Johnson has been operating for approximately 140 years, making it the more established of the two companies. Cardinal Health, Inc. has been in operation for around 55 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Cardinal Health vs Johnson & Johnson overview